BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced the pricing o…
Timolol microdrops appear as effective as conventional drops in lowering IOP
Timolol maleate 0.5% microdrops delivered with the Nanodropper Adaptor met three noninferiority endpoints in lowering IOP compared with conventional timolol drops, according to a study.“We anticipate the Nanodropper system with timolol will revolutioni…
Gene therapy improves vision in patients with retinitis pigmentosa in phase 2b trial
MCO-010 demonstrated positive topline results in vision improvement in patients with permanent and severe vision loss from advanced retinitis pigmentosa, according to a press release from Nanoscope Therapeutics.The mutation-agnostic gene therapy also d…
Terry Kim, MD, to serve as chief medical officer, head of global medical safety at Alcon
Terry Kim, MD, is joining Alcon as chief medical officer and head of global medical safety, according to a press release.In this role, Kim will help guide the integration of scientific and clinical priorities in Alcon’s surgical and vision care franchi…
Wiregrass Museum of Art to Loan EnChroma Glasses to Color Blind Visitors
DOTHAN, Ala. & BERKELEY, Calif.–(BUSINESS WIRE)– #enchroma–Wiregrass Museum of Art (WMA) and EnChroma® – creators of glasses for color blindness – today announced that WMA will loan EnChroma glasses to visitors who are red-green color blind so they …
Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced fifteen podium and four poster presentations during the American S…